NPI: 1770547036 · CHARLOTTESVILLE, VA 22911 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/13/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/13/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,329 | $182K |
| 2019 | 13,544 | $202K |
| 2020 | 11,764 | $228K |
| 2021 | 17,122 | $223K |
| 2022 | 11,669 | $187K |
| 2023 | 7,540 | $172K |
| 2024 | 162 | $699.36 |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 23,706 | 1,579 | $1.12M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 18,991 | 1,067 | $35K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 874 | 400 | $27K |
| J1756 | Injection, iron sucrose, 1 mg | 5,509 | 1,083 | $5K |
| J1270 | Injection, doxercalciferol, 1 mcg | 11,431 | 909 | $4K |
| A4657 | Syringe, with or without needle, each | 6,739 | 1,549 | $1K |
| 82728 | 694 | 504 | $228.54 | |
| 83970 | 908 | 654 | $63.72 | |
| 83540 | 724 | 538 | $10.39 | |
| 83550 | 331 | 238 | $9.60 | |
| 84466 | 542 | 432 | $9.11 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 108 | 84 | $8.31 |
| 85041 | 1,031 | 748 | $6.11 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 336 | 208 | $5.85 |
| 85048 | 982 | 715 | $5.14 | |
| 82108 | 151 | 112 | $3.95 | |
| 0124A | 15 | 15 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 58 | 40 | $0.00 |